We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Cytogel Pharma Stock

Invest in or calculate the value of your shares in Cytogel Pharma or other pre-IPO companies through EquityZen's platform.

Get Started

Cytogel Pharma Stock (CYPH)

Cytogel Pharma is a bio-pharmaceutical development company that pursues strategic opportunities for pharmaceutical product development.

About Cytogel Pharma Stock

Founded

2000

Headquarters

Darien, CT, US

Total Funding

5.1M

Industries

Software, Artificial Intelligence, Data and Analytics

Cytogel Pharma (Cytogel) is a bio-pharmaceutical development company founded in 2002 to pursue strategic opportunities for pharmaceutical product development. The company focuses on acquiring promising early-stage programs that offer significant potential both as platform technologies and high value product candidates. Milestone-defined investment of corporate resources permits the company to enhance product value for partnering or licensing, while retaining optimal equity value for our investors. Cytogel is venture backed by Centripetal Capital Partners.

Cytogel Pharma Management

Leadership team at Cytogel Pharma

CEO

C. Dean Maglaris

Licensing and Business Development

James J. Hamsher

Locked Features

Join now and verify your accreditation status to gain access to:

  • Cytogel Pharma current valuation
  • Cytogel Pharma stock price
  • Available deals in Cytogel Pharma and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Cytogel Pharma stock?

Accredited investors can buy pre-IPO stock in companies like Cytogel Pharma through EquityZen funds. These investments are made available by existing Cytogel Pharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Cytogel Pharma stock?

Shareholders can sell their Cytogel Pharma stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."